Cas no for 14636-12-5,Terlipressin ACID Cas number search msds database,online free cas number chemistry search engine,cas number sigma aldrich

Products
Suppliers
Sourcing Requests

Post Sourcing Request Exhibition

Home
Products
Supplier
E-Trade Season
Content Hub
Industry Insights
Service & Membership
For Supplier

My Account

My Online Store

My EZSourcing

View Sourcing Requests

Customer Service
For Buyer

Search Products & Suppliers
Products Directory Suppliers Discovery Post EZSourcing
Service
Buyer Sourcing Event Contact Us
Quick links
My Favorites Recent Visit History

Home > CAS No. Inquiry > 14636-12-5

14636-12-5

[CAS Name] Terlipressin

[Formula] C52H74N16O15S2

Search Products Post Sourcing Request

Basica Info

[CAS Name]Terlipressin
[Alias]n-(n-(n-glycylglycyl)glycyl)-8-l-lysinevasopressin; (2s)-1-[(4s,7s,10s,13s,16s,19s)-19-[[2-[[2-[(2-aminoacetyl)amino]acetyl]amino]acetyl]amino]-13-benzyl-10-(2-carbamoylethyl)-7-(carbamoylmethyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-n-[(1s)-5-amino-1-(carbamoylmethylcarbamoyl)pentyl]pyrrolidine-2-carboxamide; (2S)-1-{[(4R,7S,10S,13S,16S,19R)-19-{[({[(aminoacetyl)amino]acetyl}amino)acetyl]amino}-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}-N-{(2S)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl}pyrrolidine-2-carboxamide (non-preferred name)
[Number]14636-12-5
[EINECS]238-680-8
[Formula]C52H74N16O15S2
[Molecular weight]1227.3722

[Boiling point]1824°C at 760 mmHg
[Density]0mmHg at 25°C
[Flash point]1056.9°C

14636-12-5 Suppliers

Company

Main Products

HYBIO PHARMACEUTICAL CO., LTD.

Terlipressin is a synthetic vasopressin analog that primarily acts on the vasopressin V1 receptor. It's used to treat certain conditions related to portal hypertension, such as bleeding esophageal varices and hepatorenal syndrome.

Send Inquiry

HYBIO PHARMACEUTICAL CO., LTD.

Indications:

Treatment of bleeding esophageal varices in patients with cirrhosis.
Treatment of hepatorenal syndrome (HRS), particularly type 1 HRS.

Mechanism of Action: Terlipressin is a prodrug of lysine vasopressin (LVP). Upon administration, it is hydrolyzed to release LVP. LVP then acts on vasopressin V1 receptors, leading to splanchnic vasoconstriction. This helps reduce portal blood flow and pressure, thereby reducing or stopping esophageal variceal bleeding. In the case of HRS, the vasoconstrictive effect helps improve renal function.

Pharmacokinetics:

Absorption: After intravenous administration, terlipressin is rapidly hydrolyzed to LVP.
Distribution: Distributed throughout the body, mainly in the kidneys, liver, and vascular endothelium.
Metabolism: Rapidly metabolized, primarily in the liver.
Excretion: Excreted primarily through the kidneys.

Form: Terlipressin API is usually available as a white to off-white lyophilized powder.

Send Inquiry

AFINE CHEMICALS LIMITED

Standard or custom package excellent quality and reliable supplier

Send Inquiry

Previous page 1 2 3 4 5 6 7 8 Next page

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us: About PharmaSources; Terms of Service; Privacy Policy; Intellectual Property; Media Partners

Buy: Search Products; Post Sourcing Requests; Search Suppliers; CAS Search

Sell: Member Application; Advertising; Post Products; EZSourcing

Events: CPHI China; PMEC China; Conferences; Search Events

Help: FAQ; Contact Us; Feedback

Links：
CCCMHPIE SJGLE.com JJGLE.COM JDGLE.COM XIUGLE.COM DENGGLE.COM HPGLE.COM
Follow Us：
Pharma Sources Insight June 2024: Globalization on the Go

PharmaSources Customer Service